Garrison Institute on Aging to Present National Alzheimer’s Disease and Awareness Month

More than 5.8 million Americans are living with Alzheimer’s disease. The Texas Tech University Health Sciences Center (TTUHSC) Garrison Institute on Aging along with the Center for Translational Neuroscience and Therapeutics, Pharmacology and Neuroscience Department will present the “National Alzheimer’s Disease and Awareness Month” to highlight numerous aspects of the disease.

 The Garrison Institute on Aging is a collaborative initiative designed to improve brain health and quality of life in aging through innovative research, education and community outreach. Executive Director and Chief Scientific Officer Volker Neugebauer, M.D., Ph.D., said the disease represents a major health care problem in this country and worldwide.


Volker Neugebauer, M.D., Ph.D., Executive Director and Chief Scientific Officer for the Garrison Institute on Aging.

“Better understanding of disease mechanisms is needed to develop novel and improved diagnostic and therapeutic tools and strategies,” Neugebauer said. “This institute provides the infrastructure and expertise for collaborative efforts of basic scientists and clinicians from various disciplines and specialties in the area of aging-related and neurodegenerative disorders.”

 Presentations and speakers include:

Nov. 4

“10 Warning Signs of Dementia,” Joe B. Duke, M.Ed., Alzheimer’s Association

Noon, Garrison Institute on Aging, 6630, S. Quaker Ste. E

RSVP required 

Nov. 6

“Alzheimer’s & Dementia Syndromes: Could a Precision, Personalized Approach Improve Prevention and Treatment for All?” Sudha Seshadri, M.D., D.M., Glen Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, UT Health, San Antonio

Noon, TTUHSC, 3601 Fourth St., 1C124

Nov. 13

“Dementia Simulation Demonstration and Early Symptoms of Alzheimer’s Disease and Non-Alzheimer’s Dementias,” Parunyou Julayanont, M.D., TTUHSC assistant professor of Neurology

2 p.m. Dementia Simulation

3 p.m. Healthy Aging Lecture

Carillon Windsong, 4002 16th St.

Nov. 14

“Legal and Financial Planning for Alzheimer’s Disease,” Lee Franks, Franks Elder Law at Franks & Pleasant

Noon, Garrison Institute on Aging, 6630, S. Quaker Ste. E

RSVP required

Nov. 21

“Alzheimer’s Disease: A Clinical Dilemma,” John Culberson, M.D., TTUHSC Bernhard T. Mittemeyer Endowed Chair in Medical Excellence in Geriatric Medicine and associate professor in the Department of Family and Community Medicine

Noon, TTUHSC, 3601 Fourth St., 1C125A 

The events are free and open to the public. For more information or to RSVP, contact the Garrison Institute on Aging at (806) 743-7821.

Related Stories

How Does Your Garden Grow?

As spring approaches, some people’s thoughts turn to gardening. Whether it’s a flower garden they desire or a vegetable garden want to have, they begin planning what they’ll plant and what they need to do to ensure a successful garden.

Adopt a Growth Mindset for a Better Life

A “growth mindset” accepts that our intelligence and talents can develop over time, and a person with that mindset understands that intelligence and talents can improve through effort and learning.

Drug Use, Family History Can Lead to Heart Disease in Younger Adults

Abstaining from drug abuse and an early diagnosis of familial hypercholesterolemia (high cholesterol) can help prevent heart disease.

Recent Stories


Texas Tech University Health Sciences Center Names New School of Medicine Dean and Executive Vice President for Clinical Affairs

John C. DeToledo, M.D., has been named the TTUHSC School of Medicine dean and executive vice president for clinical affairs.


Finding Purpose and Perspective in West Texas

Edgar Garza, second year student in the Master of Athletic Training program, spoke about his journey to TTUHSC and his hopes to shape the future of athletic training.


Almodóvar Receives NIH Grant to Study Pulmonary Hypertension in HIV Patients

The National Heart, Lung and Blood Institute at the NIH recently awarded Sharilyn Almodóvar, Ph.D., a four-year, $2.67 million grant to study how the HIV virus damages the normal interactions between different cell types in the lung arteries that lead to the condition.